loadpatents
Patent applications and USPTO patent grants for Lai; Chunqiu.The latest application filed is for "macrocyclic mcl-1 inhibitors and methods of use".
Patent | Date |
---|---|
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20220259226 - Braje; Wilfried ;   et al. | 2022-08-18 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20210292339 - BRAJE; Wilfried ;   et al. | 2021-09-23 |
Macrocyclic MCL-1 Inhibitors and Methods of Use App 20200325153 - Judd; Andrew S. ;   et al. | 2020-10-15 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20200255451 - Kind Code | 2020-08-13 |
Macrocyclic Mcl-1 Inhibitors And Methods Of Use App 20200239494 - BRAJE; Wilfried ;   et al. | 2020-07-30 |
Macrocyclic MCL-1 inhibitors and methods of use Grant 10,676,485 - Judd , et al. | 2020-06-09 |
Macrocyclic MCL-1 Inhibitors and Methods of Use App 20200010480 - Brady; Patrick B. ;   et al. | 2020-01-09 |
Macrocyclic MCL-1 inhibitors and methods of use App 20190144465 - Judd; Andrew S. ;   et al. | 2019-05-16 |
Macrocyclic MCL-1 inhibitors and methods of use App 20190055264 - Brady; Patrick B. ;   et al. | 2019-02-21 |
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors Grant 9,796,708 - Tong , et al. October 24, 2 | 2017-10-24 |
Pyridopyrimidinone inhibitors of kinases Grant 9,718,821 - Woods , et al. August 1, 2 | 2017-08-01 |
Pyridine CDK9 kinase inhibitors Grant 9,650,358 - Mastracchio , et al. May 16, 2 | 2017-05-16 |
Tetracyclic CDK9 kinase inhibitors Grant 9,328,112 - Frey , et al. May 3, 2 | 2016-05-03 |
Pyrrolo [2,3-b] Pyridine Cdk9 Kinase Inhibitors App 20160060257 - Tong; Yunsong ;   et al. | 2016-03-03 |
Pyrrolopyridine inhibitors of kinases Grant 9,181,246 - Penning , et al. November 10, 2 | 2015-11-10 |
Pyridopyrimidinone inhibitors of kinases Grant 9,181,239 - Mastracchio , et al. November 10, 2 | 2015-11-10 |
Tetracyclic Cdk9 Kinase Inhibitors App 20150218165 - Frey; Robin ;   et al. | 2015-08-06 |
Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases Grant 9,051,327 - Zhu , et al. June 9, 2 | 2015-06-09 |
CDK9 kinase inhibitors Grant 8,969,375 - Lai , et al. March 3, 2 | 2015-03-03 |
Pyrrolopyridine Inhibitors Of Kinases App 20140357616 - Penning; Thomas D. ;   et al. | 2014-12-04 |
Pyridazino[4,5-d]pyrimidin-5(6h)-one Inhibitors Of Kinases App 20140296220 - Zhu; Gui-Dong ;   et al. | 2014-10-02 |
Pyridine Cdk9 Kinase Inhibitors App 20140275011 - Mastracchio; Anthony ;   et al. | 2014-09-18 |
Cdk9 Kinase Inhibitors App 20140275153 - Lai; Chunqiu ;   et al. | 2014-09-18 |
Pyrrolopyridine inhibitors of kinases Grant 8,822,446 - Penning , et al. September 2, 2 | 2014-09-02 |
Pyridopyrimidinone Inhibitors Of Kinases App 20130225589 - Woods; Keith W. ;   et al. | 2013-08-29 |
Pyrrolopyridine inhibitors of kinases Grant 8,435,980 - Florjancic , et al. May 7, 2 | 2013-05-07 |
Pyridopyrimidinone Inhibitors Of Kinases App 20130102590 - Mastracchio; Anthony ;   et al. | 2013-04-25 |
Pyrrolopyrazine inhibitors of kinases Grant 8,383,624 - Penning , et al. February 26, 2 | 2013-02-26 |
Pyridazino[4,5-d]pyrimidin-5(6h)-one Inhibitors Of Kinases App 20130023523 - Zhu; Gui-Dong ;   et al. | 2013-01-24 |
Pyrrolopyridine Inhibitors Of Kinases App 20110257152 - Penning; Thomas D. ;   et al. | 2011-10-20 |
Pyrrolopyrazine Inhibitors Of Kinases App 20110015172 - Penning; Thomas D. ;   et al. | 2011-01-20 |
Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,521,439 - Bishop , et al. April 21, 2 | 2009-04-21 |
Novel glucocorticoid receptor ligands for the treatment of metabolic disorders App 20070027117 - Bishop; Richard D. ;   et al. | 2007-02-01 |
Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,141,559 - Bishop , et al. November 28, 2 | 2006-11-28 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) App 20060264433 - Backes; Bradley J. ;   et al. | 2006-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.